ResearcherThomas Jefferson UniversityActive in the last 2 years

Nitzan Zohar

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9972-7207; OpenAlex author ID A5045305671. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2025: 1 paper

Papers 1

Gene Expression Profiling of Pancreatic Ductal Adenocarcinoma Cells in Hypercapnia Identifies SIAH3 as a Novel Prognostic Biomarker. Co-author DOI 10.3390/ijms26072848 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Aditi Jain · 1 shared paper, 2025 · strength 0.26
- Paper Gene Expression Profiling of Pancreatic Ductal Adenocarcinoma Cells in Hypercapnia Identifies SIAH3 as a Novel Prognost… DOI 10.3390/ijms26072848 ↗
Harish Lavu · 1 shared paper, 2025 · strength 0.26
- Paper Gene Expression Profiling of Pancreatic Ductal Adenocarcinoma Cells in Hypercapnia Identifies SIAH3 as a Novel Prognost… DOI 10.3390/ijms26072848 ↗
Charles J. Yeo · 1 shared paper, 2025 · strength 0.26
- Paper Gene Expression Profiling of Pancreatic Ductal Adenocarcinoma Cells in Hypercapnia Identifies SIAH3 as a Novel Prognost… DOI 10.3390/ijms26072848 ↗
Avinoam Nevler · 1 shared paper, 2025 · strength 0.26
- Paper Gene Expression Profiling of Pancreatic Ductal Adenocarcinoma Cells in Hypercapnia Identifies SIAH3 as a Novel Prognost… DOI 10.3390/ijms26072848 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.